申请人:AbbVie Inc.
公开号:EP3252045A1
公开(公告)日:2017-12-06
This disclosure relates to: (a) compounds and salts thereof that, inter alia, inhibit RSV infection and/or replication; (b) intermediates useful for the preparation of such compounds and salts; (c) compositions comprising such compounds and salts; (d) methods for preparing such intermediates, compounds, salts, and compositions; (e) methods of use of such compounds, salts, and compositions; and (f) kits comprising such compounds, salts, and compositions.
本公开涉及:(a) 特别是抑制 RSV 感染和/或复制的化合物及其盐类;(b) 用于制备此类化合物和盐类的中间体;(c) 包含此类化合物和盐类的组合物;(d) 制备此类中间体、化合物、盐类和组合物的方法;(e) 此类化合物、盐类和组合物的使用方法;以及 (f) 包含此类化合物、盐类和组合物的试剂盒。